Results 211 to 220 of about 47,203 (289)

Phytocannabinoids and bone health. [PDF]

Curr Osteoporos Rep
Palmer H, Roopchand DE.
europepmc   +1 more source

Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development

Annals of Neurology, Volume 100, Issue 5, Page 948-961, November 2026.
Objective Amyotrophic lateral sclerosis (ALS) has a markedly distinctive clinical and neuroradiological signature, with the preferential involvement of specific brain networks and the apparent sparing of others. The molecular underpinnings of the strikingly selective anatomical vulnerability have not been fully elucidated to date despite the potential ...
Marlene Tahedl, We Fong Siah, Jasmin Lope, Jennifer C. Hengeveld, Mark A. Doherty, Russell L. McLaughlin, Orla Hardiman, Ee Ling Tan, Alison Toomey, Jana Kleinerova, Peter Bede   +10 more
wiley   +1 more source

Jing Si Herbal Tea Aqueous Extract Modulates G‐CSF‐Induced Hematopoietic Stem and Progenitor Cells Mobilization and Mitigates Associated Pain in a Murine Model

Cell Biochemistry and Function, Volume 44, Issue 11, November 2026.
ABSTRACT Granulocyte colony‐stimulating factor (G‐CSF) is widely used for stem cell mobilization but is associated with side effects such as pain, which often discourages healthy donors. Jing Si Herbal Tea (JSHT), a novel Chinese herbal formula comprising eight different Chinese herbal medicines, has been shown to exert pleiotropic effects against ...
Ji‐Yan Lyu, Bruce Chi‐Kang Tsai, Chih‐Ying Chi, Yu‐Ling Wu, Wen‐Tsan Weng, Kai‐Hung Wang, Kuo‐Liang Yang, Chih‐Yang Huang, Shinn‐Zong Lin   +8 more
wiley   +1 more source

Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials. [PDF]

Br J Clin Pharmacol
Hamm-Buiar L, Gorski D, Kagueiama MH, Wiens A.   +3 more
europepmc   +1 more source

Long‐Term Drop‐Seizure Response Patterns to Cannabidiol According to Genetic Status in Lennox–Gastaut Syndrome

CNS Neuroscience &Therapeutics, Volume 32, Issue 11, November 2026.
Cannabidiol was associated with rapid and sustained long‐term reduction of drop seizures in patients with Lennox–Gastaut syndrome over 24 months of follow‐up. Durable treatment responses were observed across genetically heterogeneous patients, with substantial overlap in longitudinal response trajectories regardless of genetic status.
Ji‐Hoon Na, Hee yeon Cho, Hayoon Jeon, Hyunjoo Lee, Young‐Mock Lee   +4 more
wiley   +1 more source

Monitoring Injected Drug Use in Greece Through Syringe Residue Analysis: A Multicity Study Within the ESCAPE Network

Drug Testing and Analysis, Volume 18, Issue 11, Page 1407-1417, November 2026.
A total of 2121 used syringes were analyzed in Athens, Thessaloniki, and Patras between 2022 and 2024. Distinct drug‐use patterns were observed across the three cities. Benzodiazepines, pregabalin, methadone, and fentanyl were increasingly detected in 2024.
Christina Matiaki, Anastasios Trakakis, Athanasios Theocharis, Chara Parpala, Chara Kotsailidou, Alexandros Psarianos, Emmanouil Chatzichristofis, Eleni Zagelidu, Panagiota Roussou, Nikolaos Raikos, Orthodoxia Mastrogianni   +10 more
wiley   +1 more source

Potential reverse spin bias of cannabinoids versus pharmaceutical analgesics for pain treatment: a systematic review based critical interpretive synthesis of meta-analyses. [PDF]

Res Integr Peer Rev
Aviram J, Gendler Y.
europepmc   +1 more source

How Does Place of Residence Influence the Experience and Management of Chronic Non‐Malignant Pain? A Systematic Review

European Journal of Pain, Volume 30, Issue 10, November 2026.
ABSTRACT Background and Objective Chronic non‐malignant pain (CNMP) affects up to half of the UK population and one third of adults globally. Rural populations experience poorer health outcomes across several chronic conditions; however, the influence of place of residence on CNMP management, outcomes and experiences remains unclear.
Christiana Stylianou, Rosalind Adam, Fortune Kwushue, Barbara I. Nicholl   +3 more
wiley   +1 more source

Subchronic Exposure to Low-Dose Cannabidiol (CBD) and Δ⁹-Tetrahydrocannabinol (Δ⁹-THC) Nanoemulsions Suggests Low Renal Toxicity: A Preliminary Study. [PDF]

Pathophysiology
Guedes Pinto T, Rosario BDA, de Aquino PEA, Viana GSB, Ricardo NMPS, Silveira ER, Brito DHA, Zampieri D, Viana MB, Ribeiro DA.   +9 more
europepmc   +1 more source